Key Events This Week
15 Jun: Stock opens at Rs.548.40, declines 1.19% amid broader Sensex rally
16 Jun: Price rebounds to Rs.556.05 (+1.39%) following stabilising market sentiment
17 Jun: Upgrade in technical momentum noted; stock rises 2.33% to Rs.569.00
18 Jun: Quality grade and rating downgraded to Hold; stock still gains 2.46% to Rs.583.00
19 Jun: Profit-taking leads to 3.08% drop, closing at Rs.565.05
15 June 2026: Stock Opens Lower Amid Sensex Rally
National Peroxide began the week at Rs.548.40, down 1.19% from the previous close, contrasting with the Sensex’s strong 1.19% gain to 35,764.67. This divergence suggested early profit booking or sector-specific pressures impacting the stock despite broader market optimism. Volume was moderate at 980 shares, indicating cautious investor participation.
16 June 2026: Price Recovery on Stabilising Sentiment
The stock rebounded to Rs.556.05, gaining 1.39%, supported by a continued Sensex rally (+0.49%). The recovery reflected renewed buying interest as investors digested the prior day’s weakness. Volume declined to 697 shares, signalling selective accumulation rather than broad-based enthusiasm.
17 June 2026: Technical Momentum Improves, Stock Advances
National Peroxide advanced 2.33% to Rs.569.00, outpacing the Sensex’s 0.52% gain. This day coincided with the announcement of a downgrade in the company’s quality grade and investment rating by MarketsMOJO, effective 17 June. Despite the downgrade, technical indicators showed mild bullish momentum, with the stock’s price action reflecting short-term optimism. Volume increased to 930 shares, supporting the upward move.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
18 June 2026: Quality Grade Downgrade Amid Mixed Signals
On 18 June, National Peroxide’s stock price rose 2.46% to Rs.583.00, reaching the week’s high despite the downgrade in quality grade from 'Buy' to 'Hold' by MarketsMOJO. The downgrade reflected deteriorating fundamentals, including a five-year sales CAGR decline of -6.72% and a steep EBIT contraction of -24.68%. Return on Capital Employed (2.08%) and Return on Equity (2.63%) remained weak, signalling operational challenges. However, the company’s conservative leverage (Debt to EBITDA 0.85) and zero net debt position provided some financial stability.
Technically, the stock showed mild bullish momentum with positive MACD and KST indicators on weekly charts, although monthly signals remained mixed. The stock’s valuation was attractive, trading at a Price to Book ratio of 0.9 and a PEG ratio of 0.1, despite a one-year return of -22.44%. The quarter ending FY25-26 showed strong operational results, with net sales of ₹85.68 crores and PBDIT of ₹14.88 crores, supporting the short-term positive price action.
19 June 2026: Profit-Taking Leads to Price Correction
The week concluded with a 3.08% decline to Rs.565.05, as investors booked profits following the prior day’s gains. Volume was relatively low at 692 shares, indicating limited selling pressure. The Sensex also declined 0.30%, closing at 36,174.54, reflecting a broader market pullback. Despite the drop, the stock ended the week with a net gain of 1.81%, underperforming the Sensex’s 2.35% rise.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-15 | Rs.548.40 | -1.19% | 35,764.67 | +1.19% |
| 2026-06-16 | Rs.556.05 | +1.39% | 35,939.94 | +0.49% |
| 2026-06-17 | Rs.569.00 | +2.33% | 36,125.82 | +0.52% |
| 2026-06-18 | Rs.583.00 | +2.46% | 36,284.69 | +0.44% |
| 2026-06-19 | Rs.565.05 | -3.08% | 36,174.54 | -0.30% |
Key Takeaways
National Peroxide’s week was characterised by a delicate balance between fundamental concerns and technical optimism. The downgrade in quality grade and investment rating to 'Hold' highlights persistent challenges in sustaining growth and profitability, with five-year sales and EBIT trends deeply negative. Low returns on capital and equity further underscore operational inefficiencies.
Conversely, the company’s conservative debt profile and recent strong quarterly results provide some counterbalance, supporting short-term price gains. Technical indicators suggest mild bullish momentum, although mixed monthly signals counsel caution. Valuation metrics remain attractive, with a low Price to Book ratio and PEG ratio, indicating potential value despite recent underperformance.
Volume trends showed moderate investor interest, with no significant spikes, reflecting a cautious market stance amid mixed signals. The stock’s 1.81% weekly gain, while positive, lagged the Sensex’s 2.35% rise, indicating relative underperformance in a broadly bullish market.
Is National Peroxide Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Conclusion
National Peroxide Ltd’s performance over the week reflects a nuanced scenario where short-term technical improvements and quarterly earnings gains are tempered by deteriorating long-term fundamentals and a cautious investment rating. The stock’s modest 1.81% weekly appreciation, coupled with a below-average quality grade, suggests that investors should maintain a watchful stance.
While valuation metrics offer some appeal, the company’s operational challenges and limited institutional interest remain key considerations. The mixed technical signals further reinforce the need for prudence. Overall, the week’s developments justify the 'Hold' rating, signalling that any investment decisions should be carefully weighed against the company’s fundamental and market context.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
